Analytical Data
-
Gene name
ANKHD1
- Application
-
Alternative Names
MASK; VBARP; HIV-1 Vpr-binding ankyrin repeat protein; Multiple ankyrin repeats single KH domain
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IWZ3
-
Expression Region
Val204~Ala563
-
Molecular Weight
43kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANKHD1, a member of the ankyrin repeat domain-containing protein family, has gained attention in recent years due to its potential roles in various biological processes and disease mechanisms. First identified as a part of signaling pathways and cellular responses, ANKHD1 is involved in regulating protein interactions and cellular localization. Research has indicated that it may play a crucial role in modulating cellular stress responses, influencing immune responses, and participating in the regulation of gene expression. Given its diverse functional implications, understanding ANKHD1's structure and function at the molecular level is essential. Studies have suggested that the dysregulation of ANKHD1 may be linked to disorders such as cancer and autoimmune diseases, making it a potential target for therapeutic intervention. Consequently, the production of recombinant ANKHD1 protein has become a priority for researchers aiming to elucidate its biological roles and mechanisms. By utilizing recombinant DNA technology, scientists can produce large quantities of ANKHD1, allowing for in-depth analysis of its interactions with other proteins and its involvement in cellular pathways. This research not only advances the understanding of ANKHD1's function but also opens new avenues for the development of targeted therapies that could mitigate the impacts of diseases associated with its dysfunction. As such, the study of recombinant ANKHD1 protein represents a significant step forward in the quest to understand the intricate roles of this protein in health and disease.
